Home/Filings/4/0000912282-24-000116
4//SEC Filing

Whitehead Warren 4

Accession 0000912282-24-000116

CIK 0000882361other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:33 PM ET

Size

5.5 KB

Accession

0000912282-24-000116

Insider Transaction Report

Form 4
Period: 2024-02-05
Transactions
  • Award

    Director Stock Options (Right to Buy)

    2024-02-05+3,3333,333 total
    Exercise: $1.97Exp: 2034-02-05Common Shares (3,333 underlying)
Footnotes (2)
  • [F1]Converted from Canadian exercise price of C$2.67 using an exchange rate of C$1.3527 = US$1.00.
  • [F2]The options vest as follows: 50% on February 5, 2025; 25% on February 5, 2026; and 25% on February 5, 2027.

Documents

1 file

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001761449

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:33 PM ET
Size
5.5 KB